Phio Pharmaceuticals Corp Working Capital to Net Assets Ratio
Phio Pharmaceuticals Corp working capital to net assets ratio. Phio Pharmaceuticals Corp (PHIO) has a Working Capital to Net Assets ratio of 104.1% as of March 2026. Working capital of $17.14 Million (current assets of $17.40 Million minus current liabilities of $260.00K) is measured against net assets of $16.46 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. Check tangible net worth ratio of Phio Pharmaceuticals Corp to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Phio Pharmaceuticals Corp (2011–2025)
Working capital to net assets ratio of Phio Pharmaceuticals Corp from 2011 to 2025. This chart shows how Phio Pharmaceuticals Corp's Working Capital to Net Assets ratio has evolved across 15 annual periods from 2011 to 2025. As of March 2026, the ratio stands at 104.1%, reflecting working capital of $17.14 Million against net assets of $16.46 Million USD. See Phio Pharmaceuticals Corp defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.
Phio Pharmaceuticals Corp Working Capital to Net Assets Ratio by Year (2011–2025)
Phio Pharmaceuticals Corp working capital to net assets ratio by year from 2011 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for Phio Pharmaceuticals Corp from 2011 to 2025, covering 15 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see Phio Pharmaceuticals Corp assets under control.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 104.4% | $21.04 Million | $20.15 Million | $21.48 Million | $435.00K | ▲ +4.5 pp |
| 2024 | 100.0% | $4.72 Million | $4.72 Million | $5.74 Million | $1.01 Million | ▲ +0.5 pp |
| 2023 | 99.5% | $7.69 Million | $7.73 Million | $9.32 Million | $1.63 Million | ▲ +2.5 pp |
| 2022 | 96.9% | $10.51 Million | $10.84 Million | $12.45 Million | $1.94 Million | ▼ -1.8 pp |
| 2021 | 98.8% | $21.66 Million | $21.93 Million | $24.73 Million | $3.07 Million | ▼ -0.9 pp |
| 2020 | 99.6% | $12.97 Million | $13.02 Million | $15.16 Million | $2.20 Million | ▲ +5.3 pp |
| 2019 | 94.3% | $5.42 Million | $5.75 Million | $7.30 Million | $1.88 Million | ▼ -4.4 pp |
| 2018 | 98.7% | $13.41 Million | $13.58 Million | $15.15 Million | $1.74 Million | ▲ +13.2 pp |
| 2017 | 85.5% | $1.57 Million | $1.83 Million | $3.83 Million | $2.27 Million | ▼ -11.8 pp |
| 2016 | 97.3% | $10.56 Million | $10.86 Million | $13.11 Million | $2.54 Million | ▼ -0.6 pp |
| 2015 | 98.0% | $8.71 Million | $8.89 Million | $10.98 Million | $2.27 Million | ▼ -180.9 pp |
| 2014 | 278.8% | $7.65 Million | $2.75 Million | $8.99 Million | $1.33 Million | ▲ +22.5 pp |
| 2013 | 256.3% | $12.67 Million | $4.94 Million | $14.74 Million | $2.08 Million | ▲ +319.9 pp |
| 2012 | -63.6% | $3.71 Million | $-5.84 Million | $5.39 Million | $1.68 Million | ▼ -138.0 pp |
| 2011 | 74.4% | $-437.00K | $-587.00K | $1.34 Million | $1.78 Million | — |